Indoco Remedies announced that the US Food and Drug Administration (USFDA) inspected Indoco's Sterile facility (Plant II) and Solid Dosages facility (Plant III) situated at L-32/33/34 Verna Industrial Estate, Goa from 14 November till 21 November, 2018. The inspection concluded with Indoco receiving 2 minor observations, none of which are repeat in nature. This facility had received a Warning Letter from the USFDA in March 2017.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
